Brief: Opyl Says Signs Two Partnerships With Neuroendocrine Cancer Australia And Pancare Foundation
29/06/2022 02:32
June 29 (Reuters) - Opyl Ltd OPL.AX :
* SIGNS TWO PARTNERSHIPS WITH NEUROENDOCRINE CANCER
AUSTRALIA AND
PANCARE FOUNDATION
Source text for Eikon: ID:nASX2x3Y82
Further company coverage: OPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pathkey.AI
See all newsBrief: Pathkey.Ai Posts FY Loss After Tax Of A$3.7 Million
Brief: Pathkey.Ai Announces A$2.8 Million Placement
Brief: Pathkey.AI Seeks Trading Halt Pending Capital Raising Announcement
Brief: Pathkey.AI Appoints Andrew Farnsworth As CEO
Australia's Pathkey.AI soars on deal to buy semiconductor developer